Fed. Circ. Backs Wins For Eli Lilly Over Cancer Drug Patent
The Federal Circuit upheld two Eli Lilly and Co. wins over its cancer treatment drug Alimta when it ruled Friday that Dr. Reddy's and Hospira's proposed products perform equivalently to the...To view the full article, register now.
Already a subscriber? Click here to view full article